Management of Neuropathic Cervical Pain

Patient Assessment

• The patient presents with degenerative changes in the cervical spine with vertebral canal stenosis from C3-C4 to C6-C7, compression of the dural sac, and signs of chronic pre-ganglionic compromise of the right C6 and bilateral C7 segments 1, 2
• This clinical picture is consistent with neuropathic pain of cervical origin, a condition that frequently requires multimodal treatment 1

Current Therapy Analysis

Risks of Current Medication Combination

• Excessive Pregabalin dose: A dose of 600mg/day (300mg 2x/day) is at the maximum recommended limit for neuropathic pain, increasing the risk of dose-dependent adverse effects 2, 3
• Concerning drug interactions:
• Common adverse effects:

Therapeutic Adjustment Recommendations

Safer Alternative

• Reduce Pregabalin dose to 300mg/day (150mg 2x/day) 2, 3
• Maintain Duloxetine at 60mg/day 1, 5

Monitoring Recommendations

• Evaluate analgesic response after 4 weeks of treatment with the adjusted regimen 1, 2
• Monitor adverse effects, especially somnolence, dizziness, and cognitive changes 2, 3
• If pain relief is partial (average pain ≥4/10), consider additional adjustments 1

Important Considerations

• Neuropathic pain generally requires a multimodal approach, but safety should be prioritized 1, 6
• The risk of QT interval prolongation is a serious concern with these medication combinations, especially in patients with additional risk factors 4
• Higher doses of Pregabalin (600mg/day) should be reserved for refractory cases and under the supervision of a pain specialist 2, 3